ASP-3652
N/A
Report date: 2023/10/12 15:27:10
Base Information
Drug NameASP-3652
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[13]
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAstellas Pharma Europe BvAstellas Pharma IncAutobahn Therapeutics Inc
Active IndicationsN/A
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksN/A